Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1423236Generated: November 4, 2026

2-(3-methyl-1H-1,2,4-triazol-5-yl)acetic acid → (S)-1-(2-benzyl-4-(3-cyclobutyl-1-ethyl-1H-indazol-5-yl)piperazin-1-yl)-2-(3-methyl-1H-1,2,4-triazol-5-yl)ethanone

https://huagongshe.com/reaction/1423236

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2-(3-methyl-1H-1,2,4-triazol-5-yl)acetic acidHCID 7019477—
Reactant5-((S)-3-benzyl-piperazin-1-yl)-3-cyclobutyl-1-ethyl-1H-indazoleHCID 66826348—
Product(S)-1-(2-benzyl-4-(3-cyclobutyl-1-ethyl-1H-indazol-5-yl)piperazin-1-yl)-2-(3-methyl-1H-1,2,4-triazol-5-yl)ethanoneHCID 17846300037%

Reaction Steps

Prepared using the same procedure described in Example 189 from 5-((S)-3-benzyl-piperazin-1-yl)-3-cyclobutyl-1-ethyl-1H-indazole and (5-methyl-1H-[1,2,4]triazol-3-yl)-acetic acid to afford the title compound as colorless solid (61 mg, 37%). LC/MS (Method B) 3.32 min, [M+1]+ 498.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08927546B2
Source datasetuspto-grants-2015_01
ORD IDord-2e87c70eb33d4714b312b8d94fb6059a
Source noteuspto-grants-2015_01